Equity markets rise by vaccine hope, surging infections fan fear

Hong Kong - Hopes that the world can begin to return to some form of normal in the new year have been rising this month after top pharma giants announced better-than-expected results from trials of their vaccines

By AFP

  • Follow us on
  • google-news
  • whatsapp
  • telegram

Top Stories

Getco Securities Specialist traders Michael O'Connor and Douglas Johnson work at a post on the floor at the New York Stock Exchange. A lack of movement in stimulus talks on Capitol Hill and a spat between the White House and Federal Reserve over cash for emergency lending facilities were also keeping gains in check. — Reuters file
Getco Securities Specialist traders Michael O'Connor and Douglas Johnson work at a post on the floor at the New York Stock Exchange. A lack of movement in stimulus talks on Capitol Hill and a spat between the White House and Federal Reserve over cash for emergency lending facilities were also keeping gains in check. — Reuters file

Published: Mon 23 Nov 2020, 2:22 PM

Equity markets rose again Monday on growing optimism over vaccine developments but concern about surging virus cases around the world tempered sentiment once again.

A lack of movement in stimulus talks on Capitol Hill and a spat between the White House and Federal Reserve over cash for emergency lending facilities were also keeping gains in check.


Hopes that the world can begin to return to some form of normal in the new year have been rising this month after top pharma giants announced better-than-expected results from trials of their vaccines.

Oxford University and AstraZeneca announced on Monday that their joint vaccine project had shown 70 per cent efficacy.


That came after Pfizer and its German partner BioNTech said Friday they had applied for emergency use authorisation for their drug, which could be rolled out next month. Moderna is expected to make its own application soon.

And on Sunday, a top government health official said he was hopeful jabs could be given within weeks.

“Our plan is to be able to ship vaccines to the immunisation sites within 24 hours of approval” by the US Food and Drug Administration, Moncef Slaoui, head of the US government virus vaccine effort, told CNN.

Slaoui estimated 20 million people across the US could be vaccinated in December, with 30 million per month after that. Britain and Germany are also hoping to begin offering jabs next month.

The need for an inoculation has been made stark by soaring infection and death rates in the US and elsewhere as the northern hemisphere heads into winter, when viruses usually spread more.

Some US states have started imposing new restrictions, while several European countries including England and France have returned to lockdowns.

“There is a lot of enthusiasm over the vaccine news and rightly so,” Brian Jacobsen, at Wells Fargo Asset Management, told Bloomberg TV.

“The problem, from our perspective, is we first have to get through winter and this is setting us up for some downside economic surprises.”

Seoul and Bangkok led gains, each rallying nearly two percent, while Shanghai, Singapore, Taipei and Jakarta all rose more than one percent.

Sydney, Wellington, Manila and Mumbai also posted healthy gains. Tokyo was closed for a holiday.

Hong Kong gains were capped as investors fret over a resurgence in the virus in the city that many fear could see economically painful containment measures reintroduced.

Cathay Pacific tumbled more than four per cent as a planned Hong Kong-Singapore travel bubble was called off. Singapore Airlines fell just 0.2 per cent in Singapore.

“Market sentiment is likely to be caught near-term between negative Covid infection news... and positive vaccine news,” said Patrik Schowitz, a strategist at JP Morgan Asset Management.

While vaccines are on their way, investors are keeping tabs on Washington, where lawmakers remain at loggerheads on a new, badly needed stimulus — with analysts saying nothing will likely be agreed before Christmas.

Adding to the unease is concern about a spat between the White House and the Fed after Treasury Secretary Stephen Mnuchin last week refused to extend a series of programmes supporting the corporate credit market, municipal lending and small and medium-sized businesses.

He said the cash, which had not been used by the central bank, should be targeted at other pandemic-relief efforts.

But the Fed hit out at the move and observers questioned its timing.

“An emerging risk for investors is an untimely withdrawal of support for the US’s real economy, just as social mobility restrictions undermine activity for the second time this year,” said Axi’s Stephen Innes.

“Economic data will likely get worse before it gets better (and) the impact of continued lockdowns will be felt for some time before vaccines become widely available.”

In currency trading, the pound extended gains on hopes Britain and the European Union could soon announce a post-Brexit trade deal.

European Commission President Ursula von der Leyen said Friday there had been better progress in recent talks, with an 11-month deadline on December 31 for the two sides to reach an agreement.

“After difficult weeks — with very, very slow progress — now we’ve seen in the last days better progress, more movement on important files. This is good,” Von der Leyen said.


More news from